Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M97,126Revenue (TTM) $M25,134Net Margin (%)8.4Altman Z-Score2.7
Enterprise Value $M110,138EPS (TTM) $1.3Operating Margin %7.9Piotroski F-Score6
P/E(ttm)43.9Beneish M-Score-2.4Pre-tax Margin (%)10.1Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %-6.6Quick Ratio2.3Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %0.7Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow23.6y-y EBITDA Growth Rate %67.7ROA % (ttm)3.4Higher Current Ratio y-yY
Dividend Yield %1.9PEG66.4ROE % (ttm)7.7Less Shares Outstanding y-yN
Payout Ratio %88.0Shares Outstanding M1,741ROIC % (ttm)4.9Gross Margin Increase y-yN

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ABT is held by these investors:



ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wellisch Alejandro DSenior Vice President 2017-11-22Sell2,153$55.86-0.11view
Blaser Brian JExecutive Vice President 2017-11-17Sell23,866$55.550.45view
Salvadori Daniel Gesua SiveExecutive Vice President 2017-11-14Sell71,157$551.45view
Salvadori Daniel Gesua SiveExecutive Vice President 2017-10-23Sell96,603$56.21-0.73view
Salvadori Daniel Gesua SiveSenior Vice President 2017-09-26Sell62,460$52.955.38view
Contreras JaimeSenior Vice President 2017-09-22Sell52,700$51.977.37view
Fussell Stephen RExecutive Vice President 2017-08-16Sell196,550$49.512.73view
LIDDY EDWARD MDirector 2017-08-14Buy1,185$48.9613.97view
Bracken Sharon JSenior Vice President 2017-08-01Sell2,000$49.1613.51view
Blaser Brian JExecutive Vice President 2017-07-27Sell15,000$5011.6view

Quarterly/Annual Reports about ABT:

News about ABT:

Articles On GuruFocus.com
Pzena Investments Exits Staples, Sells Intel, ExxonMobil Nov 08 2017 
Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan Nov 06 2017 
Abbott Announces FDA Clearance for its Alinity™ ci-series Next-generation Diagnostic Systems Oct 31 2017 
Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Oct 30 2017 
Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Di Oct 30 2017 
AbbVie Posts Quarterly Numbers Oct 30 2017 
Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S. Oct 23 2017 
Analysts Take Action on Health Care Stocks Oct 20 2017 
A Great Place to Do Great Things: Developing Game-Changing Technology at Abbott Oct 19 2017 
Abbott Laboratories Releases 3rd-Quarter Figures Oct 18 2017 

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK